{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:26:05Z","timestamp":1776281165191,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Orkney and Shetland, the population isolates that make up the Northern Isles of Scotland, are of particular interest to multiple sclerosis (MS) research. While MS prevalence is high in Scotland, Orkney has the highest global prevalence, higher than more northerly Shetland. Many hypotheses for the excess of MS cases in Orkney have been investigated, including vitamin D deficiency and homozygosity: neither was found to cause the high prevalence of MS. It is possible that this excess prevalence may be explained through unique genetics. We used polygenic risk scores (PRS) to look at the contribution of common risk variants to MS. Analyses were conducted using ORCADES (97\/2118 cases\/controls), VIKING (15\/2000 cases\/controls) and Generation Scotland (30\/8708 cases\/controls) data sets. However, no evidence of a difference in MS-associated common variant frequencies was found between the three control populations, aside from<jats:italic>HLA-DRB1*15:01<\/jats:italic>tag SNP rs9271069. This SNP had a significantly higher risk allele frequency in Orkney (0.23,<jats:italic>p<\/jats:italic>value\u2009=\u20098\u2009\u00d7\u200910<jats:sup>\u201313<\/jats:sup>) and Shetland (0.21,<jats:italic>p<\/jats:italic>value\u2009=\u20092.3\u2009\u00d7\u200910<jats:sup>\u20136<\/jats:sup>) than mainland Scotland (0.17). This difference in frequency is estimated to account for 6 (95% CI 3, 8) out of 150 observed excess cases per 100,000 individuals in Shetland and 9 (95% CI 8, 11) of the observed 257 excess cases per 100,000 individuals in Orkney, compared with mainland Scotland. Common variants therefore appear to account for little of the excess burden of MS in the Northern Isles of Scotland.<\/jats:p>","DOI":"10.1038\/s41431-021-00914-w","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T06:04:21Z","timestamp":1622786661000},"page":"1701-1709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Contribution of common risk variants to multiple sclerosis in Orkney and Shetland"],"prefix":"10.1038","volume":"29","author":[{"given":"Catriona L. K.","family":"Barnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9405-9550","authenticated-orcid":false,"given":"Caroline","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Porteous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-5059","authenticated-orcid":false,"given":"Peter K.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5751-9178","authenticated-orcid":false,"given":"James F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"914_CR1","doi-asserted-by":"crossref","unstructured":"Tremlett H, Rieckmann P. New perspectives in the natural history of multiple sclerosis. Neurology. 2010;74:2004\u201315.","DOI":"10.1212\/WNL.0b013e3181e3973f"},{"key":"914_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","volume":"52","author":"SL Hauser","year":"2006","unstructured":"Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006;52:61\u201376.","journal-title":"Neuron"},{"key":"914_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1474-4422(03)00663-X","volume":"3","author":"DA Dyment","year":"2004","unstructured":"Dyment DA, Ebers GGC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol. 2004;3:104\u201310.","journal-title":"Lancet Neurol"},{"key":"914_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S1474-4422(04)00933-0","volume":"3","author":"RA Marrie","year":"2004","unstructured":"Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol. 2004;3:709\u201318.","journal-title":"Lancet Neurol"},{"key":"914_CR5","doi-asserted-by":"publisher","first-page":"e1001866","DOI":"10.1371\/journal.pmed.1001866","volume":"12","author":"LE Mokry","year":"2015","unstructured":"Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Leong A, et al. Vitamin D and risk of multiple sclerosis: a Mendelian Randomization study. PLoS Med. 2015;12:e1001866.","journal-title":"PLoS Med"},{"key":"914_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/01.WNL.0000081305.66687.D2","volume":"61","author":"T Riise","year":"2003","unstructured":"Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology. 2003;61:1122\u20134.","journal-title":"Neurology"},{"key":"914_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/QCO.0b013e3282f88b48","volume":"21","author":"T Holm\u00f8y","year":"2008","unstructured":"Holm\u00f8y T, Hestvik ALK. Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Curr Opin Infect Dis. 2008;21:271\u20138.","journal-title":"Curr Opin Infect Dis"},{"key":"914_CR8","doi-asserted-by":"crossref","unstructured":"Mokry LE, Ross S, Timpson NJ, Sawcer S, Smith GD, Richards JB. Obesity and multiple sclerosis: a Mendelian Randomization study. PLoS Med. 2016;13:e1002053.","DOI":"10.1371\/journal.pmed.1002053"},{"key":"914_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/brain\/awt356","volume":"137","author":"H Westerlind","year":"2014","unstructured":"Westerlind H, Ramanujam R, Uvehag D, Kuja-Halkola R, Boman M, Bottai M, et al. Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain. 2014;137:770.","journal-title":"Brain"},{"key":"914_CR10","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365:eaav7188."},{"key":"914_CR11","doi-asserted-by":"publisher","first-page":"e4565","DOI":"10.1371\/journal.pone.0004565","volume":"4","author":"DS Goodin","year":"2009","unstructured":"Goodin DS. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One. 2009;4:e4565.","journal-title":"PLoS One"},{"key":"914_CR12","doi-asserted-by":"publisher","first-page":"e1003926","DOI":"10.1371\/journal.pgen.1003926","volume":"9","author":"NA Patsopoulos","year":"2013","unstructured":"Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, Noble JA, et al. Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet. 2013;9:e1003926.","journal-title":"PLoS Genet"},{"key":"914_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1136\/jnnp-2011-301546","volume":"83","author":"EM Visser","year":"2012","unstructured":"Visser EM, Wilde K, Wilson JF, Yong KK, Counsell CE. A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city. J Neurol Neurosurg Psychiatry. 2012;83:719\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"914_CR14","doi-asserted-by":"publisher","first-page":"e0155633","DOI":"10.1371\/journal.pone.0155633","volume":"11","author":"E Weiss","year":"2016","unstructured":"Weiss E, Zgaga L, Read S, Wild S, Dunlop MG, Campbell H, et al. Farming, foreign holidays, and vitamin D in Orkney. PLoS ONE. 2016;11:e0155633.","journal-title":"PLoS ONE"},{"key":"914_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ejhg.2011.170","volume":"20","author":"RE McWhirter","year":"2012","unstructured":"McWhirter RE, McQuillan R, Visser E, Counsell C, Wilson JF. Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders. Eur J Hum Genet. 2012;20:198\u2013202.","journal-title":"Eur J Hum Genet"},{"key":"914_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(81)90454-2","volume":"318","author":"A Compston","year":"1981","unstructured":"Compston A. Multiple sclerosis in the Orkneys. Lancet. 1981;318:98.","journal-title":"Lancet"},{"key":"914_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/ije\/dys084","volume":"42","author":"BH Smith","year":"2013","unstructured":"Smith BH, Campbell A, Linksted P, Fitzpatrick B, Jackson C, Kerr SM, et al. Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol. 2013;42:689\u2013700.","journal-title":"Int J Epidemiol"},{"key":"914_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ajhg.2008.08.007","volume":"83","author":"R McQuillan","year":"2008","unstructured":"McQuillan R, Leutenegger A-L, Abdel-Rahman R, Franklin CS, Pericic M, Barac-Lauc L, et al. Runs of homozygosity in European populations. Am J Hum Genet. 2008;83:359\u201372.","journal-title":"Am J Hum Genet"},{"key":"914_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"SM Kerr","year":"2019","unstructured":"Kerr SM, Klaric L, Halachev M, Hayward C, Boutin TS, Meynert AM, et al. An actionable KCNH2 long QT syndrome variant detected by sequence and haplotype analysis in a population research cohort. Sci Rep. 2019;9:1\u201311.","journal-title":"Sci Rep"},{"key":"914_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214\u20139.","journal-title":"Nature"},{"key":"914_CR21","doi-asserted-by":"publisher","first-page":"D1001","DOI":"10.1093\/nar\/gkt1229","volume":"42","author":"D Welter","year":"2014","unstructured":"Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42:D1001\u20136.","journal-title":"Nucleic Acids Res"},{"key":"914_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa073493","volume":"357","author":"DA Hafler","year":"2007","unstructured":"Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl J Med. 2007;357:851\u201362.","journal-title":"N. Engl J Med"},{"key":"914_CR23","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ng.251","volume":"40","author":"YS Aulchenko","year":"2008","unstructured":"Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, Hillert J, et al. Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet. 2008;40:1402\u20133.","journal-title":"Nat Genet"},{"key":"914_CR24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ng.401","volume":"41","author":"PL De Jager","year":"2009","unstructured":"De Jager PL, Jia X, Wang J, de Bakker PIW, Ottoboni L, Aggarwal NT, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet. 2009;41:776\u201382.","journal-title":"Nat Genet"},{"key":"914_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng.584","volume":"42","author":"S Sanna","year":"2010","unstructured":"Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, Murru R, et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet. 2010;42:495\u20137.","journal-title":"Nat Genet"},{"key":"914_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jneuroim.2010.06.003","volume":"227","author":"S Nischwitz","year":"2010","unstructured":"Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, M\u00fcller-Sarnowski F, et al. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol. 2010;227:162\u20136.","journal-title":"J Neuroimmunol"},{"key":"914_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/gene.2011.34","volume":"12","author":"FBS Briggs","year":"2011","unstructured":"Briggs FBS, Shao X, Goldstein BA, Oksenberg JR, Barcellos LF, De Jager PL. Genome-wide association study of severity in multiple sclerosis. Genes Immun. 2011;12:615\u201325.","journal-title":"Genes Immun"},{"key":"914_CR28","doi-asserted-by":"crossref","unstructured":"Patsopoulos NA, de Bakker PIW, Steering Committees of Studies Evaluating IFN\u03b2-1b and a CCR1-Antagonist, ANZgene Consortium, GeneMSA, International Multiple Sclerosis Genetics Consortium, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol. 2011;70:897\u2013912.","DOI":"10.1002\/ana.22609"},{"key":"914_CR29","doi-asserted-by":"publisher","first-page":"e36140","DOI":"10.1371\/journal.pone.0036140","volume":"7","author":"F Matesanz","year":"2012","unstructured":"Matesanz F, Gonz\u00e1lez-P\u00e9rez A, Lucas M, Sanna S, Gay\u00e1n J, Urcelay E, et al. Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS One. 2012;7:e36140.","journal-title":"PLoS One"},{"key":"914_CR30","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/ng.396","volume":"41","author":"M Bahlo","year":"2009","unstructured":"Bahlo M, Booth DR, Broadley SA, Brown MA, Foote SJ, Griffiths LR, et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009;41:824\u20138.","journal-title":"Nat Genet"},{"key":"914_CR31","unstructured":"Phan L, Jin Y, Zhang H, Quiang W, Shekhtman E, Shao D, et al. ALFA: allele frequency aggregator. 2020. https:\/\/www.ncbi.nlm.nih.gov\/snp\/docs\/gsr\/alfa\/."},{"key":"914_CR32","first-page":"205521731664872","volume":"2","author":"JY Mescheriakova","year":"2016","unstructured":"Mescheriakova JY, Broer L, Wahedi S, Uitterlinden AG, van Duijn CM, Hintzen RQ. Burden of genetic risk variants in multiple sclerosis families in the Netherlands. Mult Scler J Exp Transl Clin. 2016;2:2055217316648721.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"914_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00415-018-9128-9","volume":"266","author":"KE Harding","year":"2019","unstructured":"Harding KE, Robertson NP. New rare genetic variants in multiple sclerosis. J Neurol. 2019;266:278\u201380.","journal-title":"J Neurol"},{"key":"914_CR34","unstructured":"Scottish Government. Scottish health survey: results for local areas 2014 to 2017. 2018.\u00a0https:\/\/www.gov.scot\/publications\/scottish-health-survey-results-local-areas-2014-2015-2016-2017\/."},{"key":"914_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/WNL.0000000000000203","volume":"82","author":"AK Hedstr\u00f6m","year":"2014","unstructured":"Hedstr\u00f6m AK, Bomfim IL, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 2014;82:865\u201372.","journal-title":"Neurology"},{"key":"914_CR36","doi-asserted-by":"publisher","first-page":"e1008480","DOI":"10.1371\/journal.pgen.1008480","volume":"15","author":"M Halachev","year":"2019","unstructured":"Halachev M, Meynert A, Taylor MS, Vitart V, Kerr SM, Klaric L, et al. Increased ultra-rare variant load in an isolated Scottish population impacts exonic and regulatory regions. PLoS Genet. 2019;15:e1008480.","journal-title":"PLoS Genet"},{"key":"914_CR37","doi-asserted-by":"publisher","first-page":"19064","DOI":"10.1073\/pnas.1904761116","volume":"116","author":"E Gilbert","year":"2019","unstructured":"Gilbert E, O\u2019Reilly S, Merrigan M, McGettigan D, Vitart V, Joshi PK, et al. The genetic landscape of Scotland and the Isles. Proc Natl Acad Sci USA. 2019;116:19064\u201370.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00914-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00914-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00914-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T19:52:49Z","timestamp":1672343569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-021-00914-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1038\/s41431-021-00914-w","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"25 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}